Tau is essential to β-amyloid-induced neurotoxicity
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present throughout the brain. Senile plaques are extracellular deposits of fibrillar β-amyloid peptide (Aβ); neurofibrillary tangles represent intracellular bundles of self-assembled hyperphosphorylated tau proteins. Although these two lesions are often present in the same brain areas, a mechanistic link between them has yet to be established. In the present study, we analyzed whether tau plays a key role in fibrillar Aβ-induced neurite degeneration in central neurons. Cultured hippocampal neurons obtained from wild-type, tau knockout, and human tau transgenic mice were treated with fibrillar Aβ. Morphological analysis indicated that neurons expressing either mouse or human tau proteins degenerated in the presence of Aβ. On the other hand, tau-depleted neurons showed no signs of degeneration in the presence of Aβ. These results provide direct evidence supporting a key role for tau in the mechanisms leading to Aβ-induced neurodegeneration in the central nervous system. In addition, the analysis of the composition of the cytoskeleton of tau-depleted neurons suggested that the formation of more dynamic microtubules might confer resistance to Aβ-mediated neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations support the idea that Aβ and Tau act together and that Aβ is upstream of Tau [114,115], positioning Aβ as the initiator and Tau as the executor in the pathogenetic process [116].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [115]
In the citing paper
“Indeed, Tau has been implicated in the synaptotoxicity induced by Aβ exposure [102].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [102]
In the citing paper
“Thus, cultured neurons from tau knockout (Tau−/−) mice are not susceptible to Aβ-induced synaptic damage and neurotoxicity (Rapoport et al., 2002; Nussbaum et al., 2012; Zempel et al., 2013) or to Aβ-induced defects in axonal transport (Vossel et al., 2011).”
From Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice (2017) · cites this paper as Rapoport et al., 2002
In the citing paper
“Neurons without tau are resistant to Aβ toxicity, and APP transgenic mice lacking tau develop Aβ pathology but remain cognitively normal (Rapoport et al., 2002; Roberson et al., 2007).”
From CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease (2018) · cites this paper as Rapoport et al., 2002
In the citing paper
“Data from cell and animal models show that tau is also a mediator of Aβ-induced toxicity46–48.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [46]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Research works printed but not linked: 2
- M P Vitek, C G Rasool, F de Sauvage, S M Vitek, R T Bartus, B Beer, R A Ashton, A F Macq, J M Maloteaux, A J Blume Brain Res 464, 121–131 (1988).
- J G Wood, S S Mirra, N L Pollock, L I Binder Proc Natl Acad Sci USA 508, 320–324 (1986).
Cited by
Items 801–900 of 971
Functional implications of tau-fyn interactions in Alzheimer's disease
Lau, H. W. D. (2015)
Jeppsson, F. (2016) · DiVA (Stockholm University)
Croft, C. L. (2016) · Research Portal (King's College London)
Neuron-to-neuron propagation of neurodegenerative proteins; relation to degradative systems
Domert, J. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-134667
Autophagy in Neurodegenerative Diseases
Moussa, C. (2019) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-05067-2_10
The Influence of Age and Alzheimer’s Pathology on Hippocampal Function
Marks, S. M. (2017) · eScholarship (California Digital Library)
Decoding the Epigenome of Neuronal Networks in Health and Disease
Jain, G. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7477
Invertebrate and Vertebrate Models of Tauopathies
Götz, J., Ittner, L. M., Götz, N. N., Lam, H., & Nicholas, H. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00069
Rôle des modifications post-traductionnelles dans le processus d’agrégation de la protéine Tau
Despres, C. (2017) · theses.fr (ABES) · doi:10.70675/de10f843z8572z4295zb672z763dbf30e2b5
Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau
Danis, C. (2018) · theses.fr (ABES) · doi:10.70675/c783a062zb57bz4024z85d0z509baaed8a1b
Modifications of the tau protein and their varied effects on aggregation and function
Combs, B. (2013) · KU ScholarWorks (The University of Kansas)
Impact of β-Amyloid on the Tau Pathology in Tau Transgenic Mouse and Tissue Culture Models
Götz, J., David, D. C., & Ittner, L. M. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_12
Granic, A. (2011) · Digital Commons - University of South Florida (University of South Florida)
Amyloid Beta: The Foremost Protagonist in Alzheimer's Disease
Anand, A., Sharma, N., Gulati, M., & Khurana, N. (2020) · IGI Global eBooks · doi:10.4018/978-1-7998-3441-0.ch001
Gan, K. J. (2014) · Summit (Simon Fraser University)
Alasmari, F. F., Al-Harbi, N. O., Alanazi, M. M., Alasmari, A. F., & Sari, Y. (2019) · Springer eBooks · doi:10.1007/978-981-13-7142-4_5
Ghani, N. S. A. (2017) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · doi:10.13140/rg.2.2.17627.98088
Non‐amyloid Approaches To Alzheimer's Disease
Veng, L., Savage, M. J., Barrow, J. C., & Zerbinatti, C. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc253
Genetic and functional studies of genes involved in the pathogenesis of Alzheimer's disease
Natunen, T. (2014) · UEF eRepo (University of Eastern Finland)
Inhibition of Alzheimer’s type toxic aggregates of tau with fungal secondary metabolites
Paranjape, S. R. (2015) · KU ScholarWorks (University of Kansas)
Duff, K., Krishnamurthy, P., Planel, E., & Hutton, M. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_13
Anderson-Mooney, A. J., & Abisambra, J. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00012-4
Paul, P. S., Borenstein-Katz, A., Shmeit, K., Wille, H., & Kar, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188152
BindingDB (2014) · UC San Diego · doi:10.7270/q2ht2qqd
Surgery, Anesthesia, and Risk for the Development of Dementia
Velkers, C. (2018) · QSpace (Queen's University Library)
CDNF in an experimental model of Parkinson's disease: studies on gene therapy and protein infusion
Bäck, S. (2014) · Helda - University of Helsinki Institutional Repository
Chaves, R. D. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-05012016-154631
Translational Biomarker Imaging
McConville, P., & Lister, D. R. (2020) · Wiley eBooks · doi:10.1002/9781119187547.ch29
Hales, C., & Levey, A. I. (2011) · Oxford University Press eBooks · doi:10.1093/obo/9780199828340-0004
PTEN and Akt signalling in Alzheimer´s disease
Rickle, A. (2005) · Figshare
Detection of novel serological biomarkers in two neurodegenerative disorders
Georgieva, Y. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-11225
Yan, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736877185.793568031
Winslow, M. (2019) · ScholarWorks (Boise State University) · doi:10.18122/td/1567/boisestate
Animal models of tau phosphorylation and tauopathy – what have they taught us?
Lau, L., & Schachter, J. B. (2004) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(04)16007-0
Wu, D., Yu, N., Gao, Y., Xiong, R., Liu, L., Lei, H., Jin, S., Liu, J., Liu, Y., Xie, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22637926
Wu, D., Yu, N., Gao, Y., Xiong, R., Liu, L., Lei, H., Jin, S., Liu, J., Liu, Y., Xie, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22637923
Wu, D., Yu, N., Gao, Y., Xiong, R., Liu, L., Lei, H., Jin, S., Liu, J., Liu, Y., Xie, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22637920
Nairn, A. C., & Leslie, S. N. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733655368.793550061
The netrin-1 receptor DCC in synaptic plasticity mechanisms underlying spatial learning and memory
Wong, E. W. (2018) · eScholarship@McGill (McGill) · doi:10.82308/53711
Bolmont, T. (2006) · edoc (University of Basel) · doi:10.5451/unibas-004159594
Identification of functional variants in the Alzheimer’s disease candidate gene ABCA7
Clement, N. S. (2017) · Nottingham ePrints (University of Nottingham)
Role of the Slingshot-Cofilin and RanBP9 pathways in Alzheimer's Disease Pathogenesis
Woo, J. A. (2015) · Digital Commons - University of South Florida (University of South Florida)
Royall, D. R. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.11.005
The localization of c-Abl in Alzheimer's disease
Jing, Z. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
Glucocorticoids and neurodegeneration
Vyas, S., Rodrigues, A. J., Silva, J. M., Tronche, F., Sousa, N., & Sotiropoulos, I. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Métabolisme et pathologie Tau dans la maladie d'Alzheimer : une relation réciproque ?
Leboucher, A. (2012) · theses.fr (ABES) · doi:10.70675/ec73e259zb56dz455az9864z4b54032702ca
Liu, Q. (2005) · OhioLink ETD Center (Ohio Library and Information Network)
Interaction du peptide beta amyloïde avec les membranes plasmiques cellulaires
Gilson, V. (2013) · theses.fr (ABES) · doi:10.70675/5a91d188zfbf8z47efza16bza77cebf6c54f
Faresjö Melander, R. (2023) · Uppsala University Publications (Uppsala University)
Research Progress on the Pathogenesis of Alzheimer’s Disease
Li, Z., & Wang, J. (2026) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2026.145007
Chapter 4. Transgenic Mice Overexpressing GSK-3 β as Animal Models for Alzheimer's Disease
Hernández, F. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732758-00052
Rôle des récepteurs adénosinergiques A2A dans la maladie d'Alzheimer
Carvalho, K. (2019) · theses.fr (ABES) · doi:10.70675/d82717c2z3bb4z4a19za654zee23c014afae
Pathological Aggregation of Cystatin C and α-Synuclein in Neurodegenerative Disease
Arscott-Barber, A. (2025) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Synthèse et évaluation biologique de ligands multi-cibles dirigés contre le système sérotoninergique
Hatat, B. (2019) · theses.fr (ABES) · doi:10.70675/50eb6d10z22edz4734za36bzc4a1894bd494
Cellular And Molecular Mechanism Of Action Of The Amyloid-Beta Oligomer Abeta Star 56
Amar, F. (2016) · University of Minnesota Digital Conservancy (University of Minnesota)
Investigating the pathogenesis of tau protein in stem cell models of neurodegenerative disease
Wallis, S. (2018) · Bristol Research (University of Bristol)
Characterization of preclinical transgenic rat models for Alzheimer’s disease-like pathology
Emmerson, J. T. (2023) · eScholarship@McGill (McGill) · doi:10.82308/166
Le polymorphisme du promoteur de l'interleukine-10 et son rôle éventuel dans la maladie d'Alzheimer
Asselineau, D. (2014) · theses.fr (ABES) · doi:10.70675/005990fbzcafez46ecz96abzefcc314e15aa
Donnier‐Maréchal, M. (2013) · theses.fr (ABES) · doi:10.70675/3214e23bz8f7fz4c45zb620z64ee487e8999
Cam, M. (2017) · theses.fr (ABES) · doi:10.70675/9cfadbadz6a4ez4260z8fe4z5caafc03a3fb
Ao, O. (2024) · eScholarship@McGill (McGill) · doi:10.82308/40971
Unraveling the structure of monomeric and fibrilized 441-residue tau with NMR spectroscopy
Bibow, S. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3545
Nouvelles fonctions de la protéine Tau dans le métabolisme des ARN
Gilles, M. (2018) · theses.fr (ABES) · doi:10.70675/68e2de7czbf1ez4cd5za43dz2c61666b771e
Sex and Genotype Influence Neurogenesis Characteristics in a Sporadic Alzheimer’s Disease Model
Xinyi Andrea, L. I. N. (2026) · TSpace (University of Toronto)
Variants rares et analyse d'exomes : application à la maladie d'Alzheimer du sujet jeune
Guennec, K. L. (2017) · theses.fr (ABES) · doi:10.70675/a8d5f155z38b8z444dzb5eaz8426b28b16d0
Identification of the modulators of and the molecular pathways involved in the BIN1-Tau interaction
Mendes, T. (2018) · theses.fr (ABES) · doi:10.70675/7f8b5d9cz1433z4dd0za940zdc3273d248b0
Robinson, A. (2016) · Research Explorer (The University of Manchester)
仲谷, 元. (2024) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002012996
Interplay of Autophagy and mTOR Signaling on Amyloid-Beta
Wycoff, S. (2026) · Digital Commons@Becker (Washington University School of Medicine) · doi:10.48765/mn25-aj64
Synthèse totale et évaluation biologique d’un inhibiteur d’origine naturelle de la kinase DYRK1A
Lucas, R. (2014) · theses.fr (ABES) · doi:10.70675/49bc2492z0781z428eza24bz69bde93b5394
Mathiesen, S. (2025) · Otago University Research Archive (University of Otago)
Biochemical characterization of extracellular Tau from in vivo models of Tau aggregation
Gomes, L. A. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
The Impact of INPP5D on Microglia Response to Tau Pathology in Alzheimer's Disease
Soni, D. (2025) · IUScholarWorks (Indiana University) · doi:10.7912/ga1a-ga83
Antibody-based Diagnostics and Therapeutics for Alzheimer's disease and Frontotemporal Dementia
(2018) · Arizona State University Library Digital Repository (Arizona State University)
Buchholz, S. (2023) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Comprehensive touchscreen characterisation of the APP/PS1 mouse model of Alzheimer’s disease
Shepherd, A. L. (2019) · Minerva Access (University of Melbourne)
MECHANISMS OF BDNF DOWN-REGULATION BY THE PATHOLOGICAL CORRELATES OF ALZHEIMER’S DISEASE
Rosa, E. (2016) · MacSphere (McMaster University) · doi:10.71548/21425
Colacurcio, D. J. (2014) · ScholarlyCommons (University of Pennsylvania)
Moseley, M. C., Smith, B. N., Moreno, J. A., Vaaga, C., & Kim, S. (2026) · doi:10.25675/3.027420
Metadata
- Authors
- Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-04-16
- Volume
- 99
- Issue
- 9
- Pages
- 6364-6369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122954
- OpenAlex
- W2081768153
- Cited by
- 807
- References
- 45
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 24 · 2022: 22 · 2021: 25 · 2020: 44 · 2019: 37 · 2018: 40 · 2017: 43 · 2016: 39 · 2015: 40 · 2014: 55 · 2013: 44 · 2012: 51
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag015383-02)
- National Institute on Aging (AG15383)
- National Institute of Neurological Disorders and Stroke (R01NS039080, NS 39080)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, amyloid-beta, Alzheimer's disease, neurotoxicity, neurite degeneration, hippocampal neurons, microtubules, cytoskeleton, amyloid plaques, neurofibrillary tangles, amyloid fibrils
- MeSH terms
- Animals, Brain, Central Nervous System, Cytoskeleton, Hippocampus, Humans, Immunohistochemistry, Mice, Transgenic, Microtubules, Phenotype, Immunoblotting, Blotting, Western, Amyloid beta-Peptides, tau Proteins, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.